x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Heart Matters

Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, and

science & medicine medicine

All Episodes

00:00:00

When More Isn't Better: Questioning the Efficacy of...

Heart Matters ·

2011/01/31

Host: Janet Wright, MD Guest: Robert Harrington, MD Recent studies have raised doubts about the efficacy of some common treatments for cardiovascular disease, including: the use of PFO closures (based on the CLOSURE trial); some methods of cardiac resynchronization therapy (or CRT, based on the SMART-AV trial); telemonitoring for patients with congestive heart failure (based on the Tele-HF trial); and doubling the dose of clopidogrel in patients who had a poor response to the drug

en

00:00:00

How to Develop Interdisciplinary, Realistic Health...

Heart Matters ·

2011/01/21

Host: Jack Lewin, MD Guest: Rashi Fein, PhD What can we learn from the past century of healthcare policy that can better inform how we develop such policies today? How has the landscape of medicine and economics surrounding health policy changed, and how have these changes influenced health policy? Join host Dr. Jack Lewin as he welcomes guest Dr. Rashi Fein, professor of the economics of medicine emeritus in the department of global health and social medicine at Harvard Medical

en

00:00:00

How to Develop Interdisciplinary, Realistic Health...

Heart Matters ·

2011/01/21

Host: Jack Lewin, MD Guest: Rashi Fein, PhD What can we learn from the past century of healthcare policy that can better inform how we develop such policies today? How has the landscape of medicine and economics surrounding health policy changed, and how have these changes influenced health policy? Join host Dr. Jack Lewin as he welcomes guest Dr. Rashi Fein, professor of the economics of medicine emeritus in the department of global health and social medicine at Harvard Medical

en

00:00:00

Does the Entire Healthcare System Need a Redesign?

Heart Matters ·

2011/01/21

Host: Jack Lewin, MD Guest: Harry Greenspun, MD Will healthcare reform do enough to alleviate the current problems in our system, or is the entire delivery model in need of a substantial re-design? Dr. Harry Greenspun, chief medical officer of Dell Services and co-author of the book Reengineering Health Care: A Manifesto for Radically Rethinking Health Care Delivery, says that while health care reform has changed payment models, reform has not done enough to change the delivery

en

00:00:00

Does the Entire Healthcare System Need a Redesign?

Heart Matters ·

2011/01/21

Host: Jack Lewin, MD Guest: Harry Greenspun, MD Will healthcare reform do enough to alleviate the current problems in our system, or is the entire delivery model in need of a substantial re-design? Dr. Harry Greenspun, chief medical officer of Dell Services and co-author of the book Reengineering Health Care: A Manifesto for Radically Rethinking Health Care Delivery, says that while health care reform has changed payment models, reform has not done enough to change the delivery

en

00:00:00

The Complexity of Medication Management for Older...

Heart Matters ·

2011/01/18

Host: Janet Wright, MD Guest: Michael Steinman, MD One of the characteristics of our older patients with heart failure is that they often have other conditions and therefore take multiple medications. How can we reduce the risk of adverse drug events among patients with heart failure and other comorbidities? Dr. Michael Steinman, associate professor of medicine at the University of California-San Francisco and the San Francisco VA Medical Center discusses the challenge of managing

en

00:00:00

Evaluation of Second Generation Drug-Eluting Stents

Heart Matters ·

2011/01/18

Guest: Richard Lange, MD, MBA Host: Janet Wright, MD First generation drug-eluting stents offer many advantages over bare metal stents, the most significant of which is their efficacy in reducing the rate of restenosis. Now second generation drug-eluting stents are proving to be even more beneficial. How are these second generation drug-eluting stents further reducing the risk of late stent thrombosis, myocardial infarction and repeat revascularization?Dr. Richard Lange, professor

en

00:00:00

Evaluation of Second Generation Drug-Eluting Stents

Heart Matters ·

2011/01/18

Host: Janet Wright, MD Guest: Richard Lange, MD, MBA First generation drug-eluting stents offer many advantages over bare metal stents, the most significant of which is their efficacy in reducing the rate of restenosis. Now second generation drug-eluting stents are proving to be even more beneficial. How are these second generation drug-eluting stents further reducing the risk of late stent thrombosis, myocardial infarction and repeat revascularization? Dr. Richard Lange, professor

en

00:00:00

Part 1: A Plant-Based Diet for Preventing and...

Heart Matters ·

2011/01/18

Host: Janet Wright, MD Guest: Caldwell Esselstyn, Jr., MD Beta blockers, anticoagulants, stenting procedures and bypass surgeries: these are all crucial cornerstones of cardiology that have saved and improved the quality of lives for our patients, yet the underlying causes of coronary artery disease aren't addressed by interventions and medications. Can we prevent and maybe even reverse heart disease by prescribing a plant-based diet? Dr. Caldwell Esselstyn, director of the

en

00:00:00

Part 1: A Plant-Based Diet for Preventing and...

Heart Matters ·

2011/01/18

Host: Janet Wright, MD Guest: Caldwell Esselstyn, Jr., MD Beta blockers, anticoagulants, stenting procedures and bypass surgeries: these are all crucial cornerstones of cardiology that have saved and improved the quality of lives for our patients, yet the underlying causes of coronary artery disease aren't addressed by interventions and medications. Can we prevent and maybe even reverse heart disease by prescribing a plant-based diet? Dr. Caldwell Esselstyn, director of the

en

00:00:00

Faster Treatment of MI with the Help of Wireless EKG...

Heart Matters ·

2010/12/08

Host: Janet Wright, MD Guest: James Scheulen, PA-C Guest: Jeffrey Trost, MD Door-to-balloon time for a patient with ST-segment elevation myocardial infarction (or STEMI) should be less than 90 minutes. Wireless electrocardiography (or EKG) programs around the country are helping to reduce door-to-balloon time by transmitting EKG data to hospitals via broadband internet, where a specialist at the hospital makes a diagnosis and prepares to treat the incoming patient. What are

en

00:00:00

PPIs and Antiplatelet Therapy: Weighing the Benefits...

Heart Matters ·

2010/11/10

Host: Janet Wright, MD Guest: Deepak Bhatt, MD One of the biggest risks of antiplatelet therapy is gastrointestinal bleeding. Because of this risk, patients on the antiplatelet clopidogrel are often prescribed proten pump inhibitors, or PPIs. However, there are also concerns about PPIs decreasing the efficacy of clopidogrel. What approach should physicians take for patients at moderate to high risk for upper GI bleeding? Host Dr. Janet Wright welcomes Dr. Deepak Bhatt, chief of

en

00:00:00

PPIs and Antiplatelet Therapy: Weighing the Benefits...

Heart Matters ·

2010/11/10

Host: Janet Wright, MD Guest: Deepak Bhatt, MD One of the biggest risks of antiplatelet therapy is gastrointestinal bleeding. Because of this risk, patients on the antiplatelet clopidogrel are often prescribed proten pump inhibitors, or PPIs. However, there are also concerns about PPIs decreasing the efficacy of clopidogrel. What approach should physicians take for patients at moderate to high risk for upper GI bleeding? Host Dr. Janet Wright welcomes Dr. Deepak Bhatt, chief of

en

00:00:00

Fortilin and Targeted Molecular Therapy for...

Heart Matters ·

2010/11/10

Guest: Ken Fujise, MD Host: Janet Wright, MD Targeted molecular therapy has been successful in cancer therapeutics. How might this approach be applied in cardiology to prevent the development of atherosclerosis?Dr. Ken Fujise, chief of cardiology at University of Texas Medical Branch, where he is also professor of medicine and biochemistry and molecular biology, talks about his preliminary research investigating the role of fortilin in the progression of atherosclerosis and

en

00:00:00

Should We Screen Asymptomatic Patients for...

Heart Matters ·

2010/10/12

Host: Janet Wright, MD Guest: Prediman Shah, MD It is apparent to most physicians that patients at high risk for having a cardiovascular event should be screened, but what about those patients who fall into the intermediate risk category (classified using the Framingham risk score)? Dr. Prediman Shah, director of the division of cardiology at Cedars-Sinai Heart Institute in Los Angeles, suggests that screening asymptomatic, intermediate-risk patients for subclinical atherosclerosis

en

00:00:00

Should We Screen Asymptomatic Patients for...

Heart Matters ·

2010/10/12

Guest: Prediman Shah, MD Host: Janet Wright, MD It is apparent to most physicians that patients at high risk for having a cardiovascular event should be screened, but what about those patients who fall into the intermediate risk category (classified using the Framingham risk score)?Dr. Prediman Shah, director of the division of cardiology at Cedars-Sinai Heart Institute in Los Angeles, suggests that screening asymptomatic, intermediate-risk patients for subclinical atherosclerosis

en

00:00:00

Methods to Identify Quality in Cardiovascular Practices

Heart Matters ·

2010/09/10

Host: Jack Lewin, MD Guest: Francois de Brantes, MS, MBA As we all strive to improve quality of care, two crucial questions remain at the heart of the issue: How do we define, and identify, quality in practices, hospitals and other health care settings? Then, how can new methods of identifying quality in practices help improve the standardization of processes and care that patients receive? Join host Dr. Jack Lewin and his guest, Francois de Brantes, executive director of the

en

00:00:00

From Haiti to the US: Public-Private Partnerships in...

Heart Matters ·

2010/09/10

Host: Jack Lewin, MD Guest: James Wilentz, MD Before the January 2010 earthquake rattled Haiti, healthcare access for the country's citizens was unreliable, but after the disaster, everything changed. How has an influx of foreign physicians impacted Haiti's healthcare system, and what lessons can the US learn from the proposed public-private partnership solutions in Haiti? Dr. James Wilentz, assistant professor of medicine at Albert Einstein College of Medicine, and co-director of

en

00:00:00

From Haiti to the US: Public-Private Partnerships in...

Heart Matters ·

2010/09/10

Host: Jack Lewin, MD Guest: James Wilentz, MD Before the January 2010 earthquake rattled Haiti, healthcare access for the country's citizens was unreliable, but after the disaster, everything changed. How has an influx of foreign physicians impacted Haiti's healthcare system, and what lessons can the US learn from the proposed public-private partnership solutions in Haiti? Dr. James Wilentz, assistant professor of medicine at Albert Einstein College of Medicine, and co-director of

en

00:00:00

Anticoagulation Therapies for Atrial Fibrillation

Heart Matters ·

2010/09/09

Host: Janet Wright, MD Guest: Stuart Connolly, MD Because atrial fibrillation increases the risk for stroke, especially among those with other underlying conditions, what anticoagulation therapies should be considered for these patients? Dr. Stuart Connolly, professor of medicine and director of the division of cardiology and the Salim Yusuf Chair in Cardiology at McMaster University in Ontario, Canada, weighs the benefits and risks of different anticoagulation therapies, in the

en

320 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事